With 203 intellectual property partners and associates in a firm of 903 lawyers, Winston & Strawn’s intellectual property practice is one of the most active in the country. The Chicago-based firm as at the forefront of high-technology, biotechnology, pharmaceutical and new-media industry litigation. George Lombardi in the Chicago office chairs the practice.
Among the cases the firm handled during 2013 were AstraZeneca PLC v. Andrx Pharmaceuticals Inc., a closely watched case in which a trial court granted a motion by Winston & Strawn partner Jim Hurst to exclude AstraZeneca’s theory of damages for infringement of patents related to Prilosec. AstraZeneca had sought more than $140 million.
